-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
CITIUS ONCOLOGY, INC. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2023 to Q2 2025.
- CITIUS ONCOLOGY, INC. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $264K, a 83.5% increase year-over-year.
- CITIUS ONCOLOGY, INC. Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2025 was $937K.
- CITIUS ONCOLOGY, INC. annual Income Tax Expense (Benefit) for 2024 was $576K, unchanged from 2023.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)